Quantcast

Latest Topiramate Stories

Qsymia: Third Weight-Loss Drug Approved BY FDA In Thirteen Years
2012-07-18 13:04:53

Lawrence LeBlond for redOrbit.com - Your Universe Online The second new weight-management drug in 13 years has been approved by US regulators for use in people who are obese or overweight and have certain medical conditions. The drug, Qsymia, developed by pharmaceutical company Vivus, received Food and Drug Administration (FDA) approval just a month after another anti-obesity drug, called Belviq, was given a thumbs up. Qsymia has been approved for use in obese adults with a body mass...

2012-06-25 23:25:24

An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston. "This new medication is promising because of the amount of weight loss it produces, the resultant improvement in important risk factors for diabetes, and, particularly in the lower dose studied, in its tolerability," said study lead author Donna H. Ryan, M.D.,...

2012-04-12 23:01:34

The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to provide consumers with information regarding the potential dangers of certain prescription medications via free online informational resources, hereby alerts the public of an FDA announcement that its decision regarding whether or not to approve the topiramate-containing obesity medication Qnexa will not be made on April 17. Instead, the agency will make...

2012-03-22 21:19:19

Drug manufacturer deviates from appropriate comparator therapy specified by the G-BA The drug retigabine (trade name: Trobalt®) was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard...

2012-03-12 07:00:00

The Consumer Justice Foundation, a for-profit corporation that is staffed by professional consumer advocates who provide free online informational resources regarding certain prescription medications at the URL of http://www.topamaxbirthinjury.com, hereby alerts the public that a panel of FDA advisers has voted to back the approval of Qnexa, an obesity drug that contains Topamax, despite a rejection of this medication by the FDA in 2010 based on concerns of Topamax-related birth defects. The...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'